SCHEMBL3309155

SCHEMBL3309155

COc1ccc(NC(=O)c2ccc(Cl)nc2)cc1.COc1ccc(NC(=O)c2cccnc2Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.60
RXFP1 Q9HBX9 1/20 0.60
NCOR2 Q9Y618 1/20 0.60
KMT2A Q03164 8/20 0.57
MEN1 O00255 7/20 0.57
RAB9A P51151 6/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
MAPK1 P28482 2/20 0.57
HTT P42858 2/20 0.57
NR2F2 P24468 1/20 0.57
MAPT P10636 3/20 0.57
GAA P10253 1/20 0.57
POLB P06746 2/20 0.55
P4HTM Q9NXG6 1/20 0.55
LMNA P02545 1/20 0.55
KCNQ3 O43525 1/20 0.55
KCNQ2 O43526 1/20 0.55
ALDH1A1 P00352 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1499710 0.89 MAPT (0.70) PPARGRXFP1NCOR2KMT2AMEN1
SCHEMBL2302302 0.87 RAB9A (0.72) KMT2AMEN1RAB9ASMN1; SMN2MAPK1
SCHEMBL3313663 0.86 LMNA (0.58) KMT2AMEN1RAB9ASMN1; SMN2MAPK1
SCHEMBL3312213 0.85 POLB (0.49) KMT2AMEN1RAB9ASMN1; SMN2MAPK1
SCHEMBL3312211 0.83 KCNQ3 (0.62) KMT2AMEN1RAB9ASMN1; SMN2HTT
SCHEMBL3309149 0.83 LMNA (0.58) KMT2AMEN1RAB9ASMN1; SMN2MAPK1
SCHEMBL5697444 0.80 TRPV1 (0.57) KMT2AMEN1RAB9ASMN1; SMN2LMNA
SCHEMBL3309586 0.80 MEN1 (0.55) PPARGNCOR2KMT2AMEN1RAB9A
SCHEMBL14096398 0.77 RAB9A (0.70) KMT2AMEN1RAB9ASMN1; SMN2MAPK1
SCHEMBL15528742 0.77 KDM4E (0.71) PPARGRXFP1NCOR2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, MOGAT2 PPARG 227/4885RXFP1 3724/4885NCOR2 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.